|Date Posted||January 24, 2020|
|Industry||Newspapers / Wires, Digital Media|
|Required Education||Bachelor's Degree|
|Salary||$35,000 to $40,000|
We're looking for an ambitious Copyeditor/Newswriter to join the biopharma reporting team at Endpoints News — the fastest growing daily publication covering the business of drug development.
This is a crucial role in our editorial organization. The Copyeditor / Newswriter is a jack-of-all-trades copy editor, someone who can ensure all our copy — and there’s a lot of it — is clean of mistakes, linked to our extensive database of stories, fact checked and stamped with the best art available.
The right candidate will also be responsible for writing a daily list short news items in our distinct Endpoints News style as well as the weekly column on the people on the move to new jobs — or out of old ones. And there will be the chance to write news stories, if that’s the course you’d like to take. You’ll be working with a team of 5 working around the globe. No previous experience necessary but we do want someone with a journalism degree and real team spirit.
As a news organization, working hours start early. The position is likely to be remote, though we do have an office in Lawrence, KS if you prefer to be based in this fun college town.
Built from the ground-up, Endpoints recently celebrated its third anniversary. We're an independent publication directed straight at the biopharma world and the executives who run it, written in a lively and authoritative style, keeping things to the point and specializing in putting news in context — translating why a story is important for readers. Our audience is global, but each reader is sitting at the virtual desk next to your own.
We publish 8-12 articles throughout the day as biopharma news breaks, neatly packaged in our daily email reports and published realtime on the web. Most of our articles are not paywalled, so they're easily discoverable by Google to brand new audiences, driving traffic on top of the core audience of newsmakers that's been following the founding team's work for well over a decade. With an audience of 2 million web visitors monthly, and 70,000 active daily email subscribers, our news reports are read closely by an elite audience employing cutting-edge science in the pursuit of profit and curing human disease.
Send your resume to this employer.